Radboud university medical center is a leading academic center for patient care, education and research, with the mission ‘to have a significant impact on healthcare’. Our activities help to improve healthcare and consequently the health of individuals and of society. We believe we can achieve that by providing excellent quality, participatory and personalized healthcare, operational excellence and by working together in sustainable networks.
Excellent quality
Patients deserve the best possible care. This is why we aim to deliver excellent quality that has to be proven. From patient care to the most prestigious research programs
Participatory and personalized healthcare
The best care for patients in general is not necessarily the best care for individuals. We develop our healthcare around patients; each of whom is seen as a member of the treatment team. Personalised healthcare means that whenever possible we match diagnostics and therapies to the specific characteristics and needs of the patient
Operational excellence
Operational excellence is a consequence of performing our jobs well through proper research, education and patient care. We ask ourselves daily if the job we do can be done better
Sustainable networks
We work with regional, national and international partners. Patients receive the best possible care where ever their needs can be best met.
In our department of Radiation Oncology, several research projects investigating the effect of tumor cell hypoxia with radiotherapy are running. The research has a strong translational character and is directed towards Head and Neck Cancer, Non Small Cell Lung Cancer and breast cancer. Current topics are focused on: analyzing EGFR signaling related to radiation resistance (PI3-K/AKT pathway related to tumor vasculature, proliferation and hypoxia involvement); non-invasive imaging of the tumor microenvironment (vasculature, hypoxia, proliferation and the EGFR) and assessment of endogenous markers related to tumor cell metabolism. Also, more recently we intensified our research directed towards oligometastatic disease, currently we coordinate a national study investigating stereotactic radiotherapy versus conventional radiotherapy for metastases of the spine. Our University has a long standing expertise in research related to basic immunological processes and the development of immunotherapy for cancer. Recently the group of prof dr G. Adema has joined our Radiation Oncology department. His work focuses on the development of new immune based combination therapies for cancer.